IRIS
D'ANGELO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.959
AS - Asia 1.071
EU - Europa 737
SA - Sud America 125
AF - Africa 23
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.884
SG - Singapore 479
HK - Hong Kong 188
RU - Federazione Russa 182
CN - Cina 168
VN - Vietnam 133
IT - Italia 115
FR - Francia 106
BR - Brasile 90
CA - Canada 60
DE - Germania 59
FI - Finlandia 54
GB - Regno Unito 51
NL - Olanda 35
SE - Svezia 33
IN - India 27
PL - Polonia 24
UA - Ucraina 20
JP - Giappone 17
AR - Argentina 15
ES - Italia 14
AT - Austria 13
BD - Bangladesh 11
IE - Irlanda 11
ZA - Sudafrica 11
MX - Messico 9
TR - Turchia 8
EC - Ecuador 7
IL - Israele 5
TH - Thailandia 5
BE - Belgio 4
LT - Lituania 4
VE - Venezuela 4
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IQ - Iraq 3
MY - Malesia 3
PK - Pakistan 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
GH - Ghana 2
ID - Indonesia 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DZ - Algeria 1
EU - Europa 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
OM - Oman 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 3.919
Salva come PNG Salva come JPEG
Città #
San Jose 318
Ashburn 258
Hong Kong 188
Council Bluffs 131
Singapore 113
Dallas 98
Fairfield 96
The Dalles 76
Beijing 75
Kent 75
Moscow 69
Lauterbourg 68
Los Angeles 58
Helsinki 50
Dong Ket 48
Chandler 43
New York 40
Woodbridge 38
Jacksonville 36
Seattle 36
Wilmington 35
Toronto 30
Boardman 29
Cambridge 29
Ho Chi Minh City 29
Houston 27
Buffalo 24
Warsaw 23
Hanoi 21
Chicago 20
Amsterdam 18
Montreal 18
Tokyo 17
Chennai 15
Frankfurt am Main 15
London 13
Orem 13
Santa Clara 12
São Paulo 12
Brooklyn 11
Dublin 11
Johannesburg 11
Nuremberg 11
Princeton 11
Atlanta 10
Munich 10
Phoenix 9
Ann Arbor 8
Assago 8
Denver 8
Düsseldorf 8
Poplar 8
Porto Sant'elpidio 8
Centro 7
Stockholm 7
Tampa 7
Vico Equense 7
Boston 6
Ankara 5
Cancellara 5
Haiphong 5
San Diego 5
Bangkok 4
Brussels 4
Camerino 4
Elk Grove Village 4
Falkenstein 4
Manchester 4
Milan 4
Mumbai 4
Rome 4
Salt Lake City 4
Sterling 4
Aprilia 3
Buenos Aires 3
Chiswick 3
City of London 3
Da Nang 3
Gustavo Adolfo Madero 3
Hangzhou 3
Hải Dương 3
Mexico City 3
Miami 3
Ogden 3
Ottawa 3
Redondo Beach 3
San Francisco 3
Tel Aviv 3
Turku 3
Accra 2
Afragola 2
Baku 2
Bari 2
Bexley 2
Brindisi 2
Brno 2
Cairo 2
Camaçari 2
Fernandópolis 2
Fresno 2
Totale 2.614
Salva come PNG Salva come JPEG
Nome #
From structure to function for the characterization of ERAP1 active site in Behçet syndrome. A novel polymorphism associated with known gene variations 183
Pistacia lentiscus Hydrosol: Untargeted Metabolomic Analysis and Anti-Inflammatory Activity Mediated by NF-κB and the Citrate Pathway 161
New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation 145
Correlation of Tumor Necrosis Factor-α −308G>A Polymorphism with Susceptibility, Clinical Manifestations, and Severity in Behçet Syndrome: Evidences from an Italian Genetic Case–Control Study 131
A First Step for the Molecular Characterization of Neurological Involvement of Behçet Syndrome: an Italian Pivotal Study 125
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study 111
Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach 99
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study 97
Identification of a de novo NLRP3 gene variation in an Italian Behçet syndrome patient 89
ERAP1 molecular characterization: Identification of a de novo allelic variant 86
TNFα rs1800629 Polymorphism and Response to Anti-TNFα Treatment in Behçet Syndrome: Data from an Italian Cohort Study 79
Assessing vitamin D levels in an anti-DFS70 positive population: New insights emerging 77
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review 76
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 72
Corticosteroid injection treatment for dactylitis in psoriatic arthritis 72
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis 67
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 65
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 64
Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach 64
Clinical phenotypes of Behçet’s syndrome in a large cohort of Italian patients: focus on gender differences 63
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 62
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 62
Ankylosing Spondylitis - Axial Spondyloarthritis (2nd ed.) 59
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 58
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 58
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 56
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis 55
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study 55
Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 55
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study 51
UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis 51
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey 47
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 45
Serum amyloid A in healthy subjects: assessment of reference value using ELISA method 45
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 44
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 43
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 42
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum 41
Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations 40
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 40
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial 39
Harmonization of ANA testing challenge: quantification strategy to accurately predict end-point titers avoiding serial dilution 37
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 37
Morphologic, dynamic and high-resolution microscopy MRI in early-onset spondyloarthritis finger dactylitis 37
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 37
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 37
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 36
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study 36
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 36
The role of adalimumab in the treatment of heart block in HLA-B27-associated disease: a case description 35
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study 35
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study 35
Understanding the Biological Significance of Anti-DFS70 Antibodies: Effect of Biologic Therapies on Their Occurrence in Inflammatory Arthritis 33
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 33
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 32
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists 32
The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis 32
Impact of the COVID-19 Pandemic on the Appropriateness of Diagnostic Pathways of Autoimmune Rheumatic Diseases 31
The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Behçet’s syndrome: a large Italian cohort study 31
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology 31
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment 30
IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment? 30
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients 28
Prevalence of Type 2 and Type 1 Diabetes in Psoriatic Arthritis 28
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 28
Toxicological considerations in the treatment of axial spondylo-arthritis 28
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 28
Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab 26
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 25
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 24
Reply to the letter to the editor: Dynamic contrast-enhanced MRI could assess the local disease activity of enthesitis and dactylitis in patients with spondyloarthritis 24
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 24
Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie 22
Real‐world effectiveness and persistence of golimumab as second‐line anti‐TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO‐BEYOND, a 12‐month prospective observational study 22
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 21
Totale 4.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.179
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 32 17 60
2021/2022141 15 15 28 18 7 5 13 7 10 4 0 19
2022/2023114 15 0 2 3 13 18 0 15 32 3 12 1
2023/202480 7 7 5 3 5 14 3 4 10 0 0 22
2024/20251.015 5 2 29 148 88 31 159 70 220 35 120 108
2025/20262.274 109 147 108 311 281 295 496 110 178 239 0 0
Totale 4.015